Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
1.270
-0.065 (-4.87%)
May 20, 2025, 9:39 AM - Market open
Prime Medicine Employees
Prime Medicine had 214 employees as of December 31, 2024. The number of employees decreased by 20 or -8.55% compared to the previous year.
Employees
214
Change (1Y)
-20
Growth (1Y)
-8.55%
Revenue / Employee
$17,972
Profits / Employee
-$943,977
Market Cap
162.33M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 214 | -20 | -8.55% |
Dec 31, 2023 | 234 | 59 | 33.71% |
Dec 31, 2022 | 175 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
PRME News
- 1 day ago - Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition - GlobeNewsWire
- 1 day ago - Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease - GlobeNewsWire
- 12 days ago - Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) - GlobeNewsWire
- 2 months ago - Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 3 months ago - Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm - PRNewsWire
- 6 months ago - Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies - Seeking Alpha